APOE and Alzheimer disease: This study demonstrates a novel pathological pathway, the ApoE‐mCRP‐CD31 pathway, in the blood‐facing endothelia that differentially affects cerebrovasculature as an AD risk in an ApoE allele‐dependent fashion, and that is likely exacerbated when peripheral chronic inflammation occurs (Figure 8 schematic).